NCT05228041View on ClinicalTrials.gov

BIOlogics in Severe Nasal POlyposis SurvEy

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval)

Drug prescription according to their marketing approval (subcutaneously, every month or every two weeks)

Trial Locations (1)

59037

RECRUITING

Hop Claude Huriez Chu Lille, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER